Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 35, Pages 21591-21602
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-07-11
DOI
10.1074/jbc.m115.652008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear Receptors License Phagocytosis by Trem2+ Myeloid Cells in Mouse Models of Alzheimer's Disease
- (2015) J. C. Savage et al. JOURNAL OF NEUROSCIENCE
- Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
- (2015) Jin Hu et al. Molecular Neurodegeneration
- The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages
- (2014) B. Daniel et al. GENES & DEVELOPMENT
- Epigenomics of macrophages
- (2014) David Gosselin et al. IMMUNOLOGICAL REVIEWS
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Nuclear receptors in neurodegenerative diseases
- (2014) Rebecca Skerrett et al. NEUROBIOLOGY OF DISEASE
- Synthesis and Identification of New Flavonoids Targeting Liver X Receptor β Involved Pathway as Potential Facilitators of Aβ Clearance with Reduced Lipid Accumulation
- (2013) Yun Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology
- (2013) Panayiota Papadopoulos et al. PLoS One
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Microglia and Inflammation in Alzheimers Disease
- (2012) Shweta Mandrekar-Colucci et al. CNS & Neurological Disorders-Drug Targets
- Regulation of microglia activation and deactivation by nuclear receptors
- (2012) Kaoru Saijo et al. GLIA
- Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPAR and ERK MAPK Signaling Pathways
- (2012) L. A. Denner et al. JOURNAL OF NEUROSCIENCE
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor- -Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
- (2012) S. Mandrekar-Colucci et al. JOURNAL OF NEUROSCIENCE
- Liver X receptor activation attenuates inflammatory response and protects cholinergic neurons in APP/PS1 transgenic mice
- (2012) W. Cui et al. NEUROSCIENCE
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD and wild-type mice
- (2012) F Masciopinto et al. Cell Death & Disease
- Macrophage polarization in metabolic disorders
- (2011) Giulia Chinetti-Gbaguidi et al. CURRENT OPINION IN LIPIDOLOGY
- Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels
- (2011) C. Y. Daniel Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ1–42 in APP/PS1 Mice
- (2011) Julie-Ann O’Reilly et al. Journal of Neuroimmune Pharmacology
- Sensory Network Dysfunction, Behavioral Impairments, and Their Reversibility in an Alzheimer's -Amyloidosis Mouse Model
- (2011) D. W. Wesson et al. JOURNAL OF NEUROSCIENCE
- Critical Role of Astroglial Apolipoprotein E and Liver X Receptor- Expression for Microglial A Phagocytosis
- (2011) D. Terwel et al. JOURNAL OF NEUROSCIENCE
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status
- (2010) Jennifer Rodriguez-Rivera et al. BEHAVIOURAL BRAIN RESEARCH
- Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
- (2010) JWA van der Hoorn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Control of Macrophage Activation and Function by PPARs
- (2010) Ajay Chawla CIRCULATION RESEARCH
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
- (2010) James J. Donkin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroinflammatory processes in Alzheimer’s disease
- (2010) Michael T. Heneka et al. JOURNAL OF NEURAL TRANSMISSION
- Liver X Receptor Agonist Treatment Ameliorates Amyloid Pathology and Memory Deficits Caused by High-Fat Diet in APP23 Mice
- (2010) N. F. Fitz et al. JOURNAL OF NEUROSCIENCE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR
- (2009) Noelia A-Gonzalez et al. IMMUNITY
- Peroxisome Proliferator-activated Receptor γ Stimulation of Adipocyte ApoE Gene Transcription Mediated by the Liver Receptor X Pathway
- (2009) Lili Yue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human APOE Isoform-Dependent Effects on Brain -Amyloid Levels in PDAPP Transgenic Mice
- (2009) K. R. Bales et al. JOURNAL OF NEUROSCIENCE
- Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
- (2009) E M Toledo et al. MOLECULAR PSYCHIATRY
- Liver X receptor activation restores memory in aged AD mice without reducing amyloid
- (2009) Tim Vanmierlo et al. NEUROBIOLOGY OF AGING
- apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
- (2008) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins
- (2008) A. R. Tall JOURNAL OF INTERNAL MEDICINE
- Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor Agonist
- (2008) N. Nicolakakis et al. JOURNAL OF NEUROSCIENCE
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started